Harvard Bioscience Stock Price (NASDAQ:HBIO)

Add to My Stocks
$4.7 $0.15 (3.3%) HBIO stock closing price Feb 16, 2018 (Closing)
Prev Close* : $4.55
Market Cap:
$163.94M
Day Low: $4.5
52 Week Low: $2.25
Open: $4.6
Volume: -
Day High: $4.75
52 Week High: $4.85
Dividend:
0.00

Latest Stock Market News

Latest Articles

Harvard Bioscience News - From Partners

HBIO Stockcharts

View HBIO PE ratio, PS ratio stocks charts and compare with peers.
HBIO Chart
Note: Compare Harvard Bioscience stock price history with the index and industry peers.

Harvard Bioscience Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
1.62
PB ratio (
price to book ratio
)
2.2

Harvard Bioscience Returns

ROE
(return on equity)
-4%

Harvard Bioscience Financial Ratios

Asset Turnover
0.91
Receivables Turnover
5.01
Debt to Equity
0.16
Dividend Yield
0%

HBIO Industry Peers

Company Price Change (%)
Newport (NEWP)22.990.02 (0.09%)
Mts Systems (MTSC)48.850.05 (0.1%)
Perkinelmer (PKI)76.390.04 (0.05%)
Danaher (DHR)97.540.07 (0.07%)
Agilent (A)71.970.05 (0.07%)
Mettler-toledo (MTD)634.372.4 (0.38%)
Danaher (DHR)97.540.07 (0.07%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Harvard Bioscience (HBIO)4.70.15 (3.3%)
Mettler-Toledo (MTD)634.372.4 (0.38%)
MTS Systems (MTSC)48.850.05 (0.1%)
Top gainers from Instruments-Scientific industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Bruker Corp (BRKR)32.10.2 (0.62%)
Waters (WAT)206.180.72 (0.35%)
PerkinElmer (PKI)76.390.04 (0.05%)
Top losers from Instruments-Scientific industry
* As of Feb 17, 2018

Harvard Bioscience Financial Statements

income statement20162015201420132012
Net Sales or Revenues104.52M108.66M108.66M105.17M111.17M
Net Income-4.3M-19.03M2.35M-1.83M2.37M
Total Operating Expense51.4M50.42M42.71M46.15M49.24M
View Harvard Bioscience income statement
balance sheet20162015201420132012
Total Assets107.76M120.21M135.91M135.46M133.48M
Total Liabilities35.56M42.61M40.44M40.97M29.27M
Shareholders Equity72.19M77.59M95.46M94.48M104.21M
View Harvard Bioscience balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-0.04M-2.71M-4.51M1.94M-
Net Cash from (used by) Operating Activities5.38M-4.35M4.06M8.06M
Increase (Decrease) in Prop Plant And Equipment-1.44M-2.95M-0.86M-1.55M-1.73M
View Harvard Bioscience cash flow statement

Harvard Bioscience Stock Message Board

Harvard Bioscience stock gained 3.3%, and the last close price as of Feb 16, 2018 is $4.7 for HBIO stock. Looking at Harvard Bioscience market capitalization, which currently stands at $163.94M, we can say that HBIO stock is a Micro Cap stock. Harvard Bioscience valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of Harvard Bioscience stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Harvard Bioscience stock quote data shows the number of shares traded. For Ex: 116,847 Harvard Bioscience shares were traded as of last trading day, as seen from Harvard Bioscience stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Harvard Bioscience stock dividend was 0.00 during the last quarter. Harvard Bioscience stock price history, gives the entire historical data for HBIO stock.